Last updated on September 2016

A long-term 4+ year, double blind placebo controlled study to evaluate the effects of bexagliflozin on hemoglobin A1c in patients with type 2 diabetes and increased risk of cardiovascular adverse events


Contact Investigators or Research Sites near you

Start Over

Jeffrey D. Wayne, MD

Clinical Trials Research
Lincoln, CA USA
  Connect »